Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Unfavorable, complex, and monosomal karyotypes: the most challenging forms of acute myeloid leukemia.

Orozco JJ, Appelbaum FR.

Oncology (Williston Park). 2012 Aug;26(8):706-12.

2.

Prognostic value of monosomal karyotype in comparison to complex aberrant karyotype in acute myeloid leukemia: a study on 824 cases with aberrant karyotype.

Haferlach C, Alpermann T, Schnittger S, Kern W, Chromik J, Schmid C, Pielken HJ, Kreuzer KA, Höffkes HG, Haferlach T.

Blood. 2012 Mar 1;119(9):2122-5. doi: 10.1182/blood-2011-10-385781. Epub 2011 Dec 29.

3.

Acute myeloid leukemia: 2012 update on diagnosis, risk stratification, and management.

Estey EH.

Am J Hematol. 2012 Jan;87(1):89-99. doi: 10.1002/ajh.22246.

4.

Acute myeloid leukemia: 2013 update on risk-stratification and management.

Estey EH.

Am J Hematol. 2013 Apr;88(4):318-27. doi: 10.1002/ajh.23404. Review.

5.

Prognosis of acute myeloid leukemia harboring monosomal karyotype in patients treated with or without allogeneic hematopoietic cell transplantation after achieving complete remission.

Yanada M, Kurosawa S, Yamaguchi T, Yamashita T, Moriuchi Y, Ago H, Takeuchi J, Nakamae H, Taguchi J, Sakura T, Takamatsu Y, Waki F, Yokoyama H, Watanabe M, Emi N, Fukuda T.

Haematologica. 2012 Jun;97(6):915-8. doi: 10.3324/haematol.2011.058289. Epub 2011 Dec 16.

6.

Stratification of de novo adult acute myelogenous leukemia with adverse-risk karyotype: can we overcome the worse prognosis of adverse-risk group acute myelogenous leukemia with hematopoietic stem cell transplantation?

Yoon JH, Kim HJ, Shin SH, Lee SE, Cho BS, Eom KS, Kim YJ, Lee S, Min CK, Cho SG, Kim DW, Lee JW, Min WS, Park CW.

Biol Blood Marrow Transplant. 2014 Jan;20(1):80-8. doi: 10.1016/j.bbmt.2013.10.015. Epub 2013 Oct 20.

7.

Chromosome abnormalities at onset of complete remission are associated with worse outcome in patients with acute myeloid leukemia and an abnormal karyotype at diagnosis: CALGB 8461 (Alliance).

Niederwieser C, Nicolet D, Carroll AJ, Kolitz JE, Powell BL, Kohlschmidt J, Stone RM, Byrd JC, Mrózek K, Bloomfield CD.

Haematologica. 2016 Dec;101(12):1516-1523. Epub 2016 Jul 28.

8.

Different prognosis of acute myeloid leukemia harboring monosomal karyotype with total or partial monosomies determined by FISH: retrospective PALG study.

Wawrzyniak E, Wierzbowska A, Kotkowska A, Siemieniuk-Rys M, Robak T, Knopinska-Posluszny W, Klonowska A, Iliszko M, Woroniecka R, Pienkowska-Grela B, Ejduk A, Wach M, Duszenko E, Jaskowiec A, Jakobczyk M, Mucha B, Kosny J, Pluta A, Grosicki S, Holowiecki J, Haus O.

Leuk Res. 2013 Mar;37(3):293-9. doi: 10.1016/j.leukres.2012.10.022. Epub 2012 Dec 14.

PMID:
23254155
9.

Chromosomal aberrations in 17p predict in vitro drug resistance and short overall survival in acute myeloid leukemia.

Nahi H, Lehmann S, Bengtzen S, Jansson M, Möllgård L, Paul C, Merup M.

Leuk Lymphoma. 2008 Mar;49(3):508-16. doi: 10.1080/10428190701861645.

PMID:
18297528
10.

CD11b expression correlates with monosomal karyotype and predicts an extremely poor prognosis in cytogenetically unfavorable acute myeloid leukemia.

Chen MH, Atenafu E, Craddock KJ, Brandwein J, Chang H.

Leuk Res. 2013 Feb;37(2):122-8. doi: 10.1016/j.leukres.2012.09.019. Epub 2012 Oct 23.

PMID:
23092917
11.

Monosomal karyotype in acute myeloid leukemia defines a distinct subgroup within the adverse cytogenetic risk category.

Voutiadou G, Papaioannou G, Gaitatzi M, Lalayanni C, Syrigou A, Vadikoliou C, Saloum R, Anagnostopoulos A, Athanasiadou A.

Cancer Genet. 2013 Jan-Feb;206(1-2):32-6. doi: 10.1016/j.cancergen.2012.10.003. Epub 2012 Dec 14.

PMID:
23246518
12.

[Cytogentic and prognostic characteristic of acute myeloid leukemia with monosomal karyotype].

Li Z, Wei H, Lin D, Zhou CL, Liu BC, Wang Y, Liu KQ, Li W, Gong BF, Wei SN, Zhang GJ, Zhao XL, Li Y, Liu YT, Gong XY, Gu RX, Qiu SW, Mi YC, Wang JX.

Zhonghua Xue Ye Xue Za Zhi. 2016 May 14;37(5):366-71. doi: 10.3760/cma.j.issn.0253-2727.2016.05.003. Chinese.

PMID:
27210869
13.

Dismal prognostic value of monosomal karyotype in elderly patients with acute myeloid leukemia: a GOELAMS study of 186 patients with unfavorable cytogenetic abnormalities.

Perrot A, Luquet I, Pigneux A, Mugneret F, Delaunay J, Harousseau JL, Barin C, Cahn JY, Guardiola P, Himberlin C, Recher C, Vey N, Lioure B, Ojeda-Uribe M, Fegueux N, Berthou C, Randriamalala E, Béné MC, Ifrah N, Witz F; Groupe Ouest-Est des Leucémies Aiguës et Maladies du Sang.

Blood. 2011 Jul 21;118(3):679-85. doi: 10.1182/blood-2010-09-307264. Epub 2011 May 26.

14.

Cytogenetic abnormalities and monosomal karyotypes in children and adolescents with acute myeloid leukemia: correlations with clinical characteristics and outcome.

Manola KN, Panitsas F, Polychronopoulou S, Daraki A, Karakosta M, Stavropoulou C, Avgerinou G, Hatzipantelis E, Pantelias G, Sambani C, Pagoni M.

Cancer Genet. 2013 Mar;206(3):63-72. doi: 10.1016/j.cancergen.2013.01.001. Epub 2013 Feb 12.

PMID:
23411131
15.

BAALC overexpression retains its negative prognostic role across all cytogenetic risk groups in acute myeloid leukemia patients.

Damiani D, Tiribelli M, Franzoni A, Michelutti A, Fabbro D, Cavallin M, Toffoletti E, Simeone E, Fanin R, Damante G.

Am J Hematol. 2013 Oct;88(10):848-52. doi: 10.1002/ajh.23516. Epub 2013 Jul 23.

16.

Monosomal karyotype in adult acute myeloid leukemia: prognostic impact and outcome after different treatment strategies.

Kayser S, Zucknick M, Döhner K, Krauter J, Köhne CH, Horst HA, Held G, von Lilienfeld-Toal M, Wilhelm S, Rummel M, Germing U, Götze K, Nachbaur D, Schlegelberger B, Göhring G, Späth D, Morlok C, Teleanu V, Ganser A, Döhner H, Schlenk RF; German-Austrian AML Study Group.

Blood. 2012 Jan 12;119(2):551-8. doi: 10.1182/blood-2011-07-367508. Epub 2011 Nov 16.

17.

Prognostic impact of specific chromosomal aberrations in a large group of pediatric patients with acute myeloid leukemia treated uniformly according to trial AML-BFM 98.

von Neuhoff C, Reinhardt D, Sander A, Zimmermann M, Bradtke J, Betts DR, Zemanova Z, Stary J, Bourquin JP, Haas OA, Dworzak MN, Creutzig U.

J Clin Oncol. 2010 Jun 1;28(16):2682-9. doi: 10.1200/JCO.2009.25.6321. Epub 2010 May 3.

PMID:
20439630
18.

TP53 alterations in acute myeloid leukemia with complex karyotype correlate with specific copy number alterations, monosomal karyotype, and dismal outcome.

Rücker FG, Schlenk RF, Bullinger L, Kayser S, Teleanu V, Kett H, Habdank M, Kugler CM, Holzmann K, Gaidzik VI, Paschka P, Held G, von Lilienfeld-Toal M, Lübbert M, Fröhling S, Zenz T, Krauter J, Schlegelberger B, Ganser A, Lichter P, Döhner K, Döhner H.

Blood. 2012 Mar 1;119(9):2114-21. doi: 10.1182/blood-2011-08-375758. Epub 2011 Dec 20.

19.

Acute myeloid leukemia with monosomal karyotype at the far end of the unfavorable prognostic spectrum.

Breems DA, Löwenberg B.

Haematologica. 2011 Apr;96(4):491-3. doi: 10.3324/haematol.2011.043208. No abstract available.

20.

Outcome of high-risk acute myeloid leukemia after allogeneic hematopoietic cell transplantation: negative impact of abnl(17p) and -5/5q-.

Middeke JM, Beelen D, Stadler M, Göhring G, Schlegelberger B, Baurmann H, Bug G, Bellos F, Mohr B, Buchholz S, Schwerdtfeger R, Martin H, Hegenbart U, Ehninger G, Bornhäuser M, Schetelig J; Cooperative German Transplant Study Group.

Blood. 2012 Sep 20;120(12):2521-8. Epub 2012 Jul 31.

Supplemental Content

Support Center